Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor Vβ Gene Expansion
暂无分享,去创建一个
[1] D. Leung,et al. A potential role for superantigens in the pathogenesis of psoriasis. , 1993, The Journal of investigative dermatology.
[2] W. Noble,et al. Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. , 1983, Journal of medical microbiology.
[3] K. Asadullah,et al. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. , 1996, The Journal of investigative dermatology.
[4] P. Marrack,et al. Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.
[5] Y. Tokura,et al. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. , 1992, The Journal of investigative dermatology.
[6] G. Wood,et al. Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to treatment , 1993, CA: a cancer journal for clinicians.
[7] H. Koh,et al. Sézary syndrome: diagnosis, prognosis, and critical review of treatment options. , 1990, Journal of the American Academy of Dermatology.
[8] P. Marrack,et al. The staphylococcal enterotoxins and their relatives. , 1990, Science.
[9] Haralampos J. Milionis,et al. Cutaneous T-cell lymphoma. , 2005, The Journal of dermatologic surgery and oncology.
[10] P. E. Shapiro,et al. The Histologic Spectrum of Mycosis Fungoides/Sézary Syndrome (Cutaneous T‐Cell Lymphoma): A Review of 222 Biopsies, Including Newly Described Patterns and the Earliest Pathologic Changes , 1994, The American journal of surgical pathology.
[11] R. Edelson,et al. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. , 1994, Archives of dermatology.
[12] S. Walker,et al. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. , 1993, The Journal of clinical investigation.
[13] P. Schlievert,et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome , 1993, The Lancet.
[14] P. Marrack,et al. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] E. Noordijk,et al. Cutaneous T‐cell lymphoma: clinicopathological relationships, therapy and survival in ninety‐two patients , 1982, The British journal of dermatology.
[16] K Wolff,et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.
[17] M. Duvic,et al. Photopheresis therapy for cutaneous T-cell lymphoma. , 1996, Journal of the American Academy of Dermatology.
[18] D. Carlo,et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Duvic. Staphylococcal infections and the pruritus of AIDS-related complex. , 1987, Archives of dermatology.
[20] C. Janeway. Are There Cellular Superantigens? , 1993, Immunological reviews.
[21] S. Rosenberg,et al. Dermatologic changes associated with interleukin 2 administration. , 1987, JAMA.
[22] E. Coutavas,et al. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. , 1995, The Journal of clinical investigation.
[23] R. Warnke,et al. Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. , 1992, The American journal of pathology.
[24] H. Mcdevitt,et al. Autoimmune diseases: the failure of self tolerance. , 1990, Science.
[25] A. Jack,et al. Cutaneous T-cell lymphoma cells employ a restricted range of T-cell antigen receptor variable region genes. , 1990, The American journal of pathology.
[26] D. Carlo,et al. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Duvic,et al. Emergence of leprosy in a patient with mycosis fungoides. , 1994, Journal of the American Academy of Dermatology.
[28] J. Mcfadden,et al. Superantigenic exotoxin‐secreting potential of staphylococci isolated from atopic eczematous skin , 1993, The British journal of dermatology.
[29] F. Sigaux,et al. Expression of Vβ Gene Segments by Sezary Cells , 1995 .
[30] S. Tyler,et al. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction , 1991, Journal of clinical microbiology.
[31] J. Musser,et al. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. , 1993, The Journal of clinical investigation.
[32] Don C. Wiley,et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen , 1994, Nature.
[33] G. Rovera,et al. Molecular diagnosis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangements. , 1991, The Journal of investigative dermatology.
[34] B. Jegasothy,et al. Cutaneous T-cell lymphoma: utility of antibodies to the variable regions of the human T-cell antigen receptor. , 1992, Journal of the American Academy of Dermatology.
[35] B. Fleischer,et al. Major histocompatibility complex class II‐associated peptides determine the binding of the superantigen toxic shock syndrome toxin‐1 , 1995, European journal of immunology.
[36] T. Kohsaka,et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Ahmed,et al. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. , 1975, Annals of internal medicine.
[38] B. Safai,et al. Association of HLA-DR5 with mycosis fungoides. , 1983, The Journal of investigative dermatology.
[39] M. Delmée,et al. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR , 1995, Journal of clinical microbiology.
[40] R. Cook,et al. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. , 1989, Science.
[41] H. Schrezenmeier,et al. T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures. , 1989, Cellular immunology.
[42] J. Musser,et al. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination , 1992, Journal of clinical microbiology.
[43] M. Duvic,et al. Cutaneous T-cell lymphoma after blood transfusion , 1993, The Lancet.
[44] K. Smith,et al. Staphylococcus aureus carriage and HIV-1 disease: association with increased mucocutaneous infections as well as deep soft-tissue infections and sepsis. , 1994, Archives of dermatology.
[45] A. Deisseroth,et al. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? , 1995, Blood.
[46] R. Sékaly,et al. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens , 1994, The Journal of experimental medicine.
[47] L. Steinman,et al. Characterization of T‐Cell Receptor αβ Repertoire in Synovial Tissue from Different Temporal Phases of Rheumatoid Arthritis , 1992 .
[48] L. Skov,et al. Superantigens. Do they have a role in skin diseases? , 1995, Archives of dermatology.
[49] X. Yan,et al. Involvement of HLA class II molecules in acquisition of staphylococcal enterotoxin A‐binding activity and accessory cell activity in activation of human T cells by related toxins in vascular endothelial cells , 1992, Clinical and experimental immunology.
[50] Y. Tokura,et al. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens , 1995, The British journal of dermatology.
[51] R. Klausner,et al. The T‐Cell Antigen Receptor , 1988, Annals of the New York Academy of Sciences.
[52] R. Balderas,et al. Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome. , 1992, The American journal of pathology.
[53] A. Menter,et al. Cutaneous T-cell lymphoma in association with silicone breast implants. , 1995, Journal of the American Academy of Dermatology.
[54] T. Whittam,et al. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics , 1986, Applied and environmental microbiology.
[55] M. Duvic,et al. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. , 1996, The Journal of investigative dermatology.
[56] S. Malka,et al. Mycosis fungoides—a disease of antigen persistence , 1974, The British journal of dermatology.
[57] M. Duvic,et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. , 1987, Archives of dermatology.
[58] R. Warnke,et al. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. , 1993, The Journal of investigative dermatology.
[59] G. Clayman,et al. Keratinocyte transglutaminase expression varies in squamous cell carcinomas. , 1994, The Journal of investigative dermatology.
[60] C. Berger,et al. Malignant and normal T cells show random use of T-cell receptor alpha chain variable regions in patients with cutaneous T-cell lymphoma. , 1995, The Journal of investigative dermatology.
[61] H. Sampson,et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. , 1993, The Journal of clinical investigation.
[62] M. Bigby,et al. T-cell receptor V beta expression in normal human skin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[63] R. Cook,et al. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. , 1991, Journal of immunology.